Boston Common Asset Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.16M | Sell |
108,285
-1,231
| -1% | -$99.3K | 0.54% | 58 |
|
|
2026
Q1 | $7.74M | Sell |
109,516
-13,810
| -11% | -$1.03M | 0.5% | 62 |
|
|
2025
Q4 | $9.74M | Sell |
123,326
-59,582
| -33% | -$4.72M | 0.59% | 54 |
|
|
2025
Q3 | $15.1M | Buy |
182,908
+5,021
| +3% | +$395K | 0.42% | 83 |
|
|
2025
Q2 | $14.3M | Sell |
177,887
-39,706
| -18% | -$3.06M | 0.4% | 90 |
|
|
2025
Q1 | $17.5M | Buy |
217,593
+21,051
| +11% | +$1.75M | 0.53% | 69 |
|
|
2024
Q4 | $16.1M | Buy |
196,542
+34,412
| +21% | +$2.86M | 0.47% | 81 |
|
|
2024
Q3 | $13.4M | Sell |
162,130
-496
| -0.3% | -$37.1K | 0.35% | 107 |
|
|
2024
Q2 | $11.4M | Sell |
162,626
-6,087
| -4% | -$435K | 0.29% | 117 |
|
|
2024
Q1 | $12.5M | Sell |
168,713
-84,199
| -33% | -$5.87M | 0.3% | 115 |
|
|
2023
Q4 | $16.7M | Sell |
252,912
-13,158
| -5% | -$823K | 0.38% | 99 |
|
|
2023
Q3 | $16.7M | Buy |
266,070
+11,597
| +5% | +$722K | 0.4% | 94 |
|
|
2023
Q2 | $14.4M | Sell |
254,473
-105,088
| -29% | -$5.83M | 0.31% | 120 |
|
|
2023
Q1 | $20.8M | Sell |
359,561
-11,408
| -3% | -$770K | 0.43% | 84 |
|
|
2022
Q4 | $26.8M | Buy |
370,969
+92,884
| +33% | +$6.65M | 1.28% | 19 |
|
|
2022
Q3 | $16.9M | Buy |
+278,085
| New | +$17.8M | 0.89% | 40 |
|
|
2018
Q4 | – | Sell |
-29,149
| Closed | -$1.36M | – | 190 |
|
|
2018
Q3 | $1.36M | Buy |
29,149
+3,190
| +12% | +$146K | 0.17% | 106 |
|
|
2018
Q2 | $1.13M | Buy |
25,959
+5,300
| +26% | +$247K | 0.14% | 110 |
|
|
2018
Q1 | $948K | Buy |
20,659
+908
| +5% | +$44.1K | 0.11% | 143 |
|
|
2017
Q4 | $999K | Sell |
19,751
-9,627
| -33% | -$507K | 0.12% | 135 |
|
|
2017
Q3 | $1.53M | Buy |
29,378
+68
| +0.2% | +$3.31K | 0.19% | 92 |
|
|
2017
Q2 | $1.44M | Sell |
29,310
-583
| -2% | -$27K | 0.19% | 94 |
|
|
2017
Q1 | $1.41M | Sell |
29,893
-738
| -2% | -$35.2K | 0.19% | 95 |
|
|
2016
Q4 | $1.47M | Buy |
30,631
+623
| +2% | +$28.6K | 0.21% | 93 |
|
|
2016
Q3 | $1.19M | Buy |
30,008
+9,930
| +49% | +$373K | 0.06% | 176 |
|
|
2016
Q2 | $713K | Buy |
20,078
+1,711
| +9% | +$66.7K | 0.04% | 211 |
|
|
2016
Q1 | $719K | Buy |
+18,367
| New | +$687K | 0.04% | 215 |
|
|
2015
Q2 | – | Sell |
-89,322
| Closed | -$4.02M | – | 278 |
|
|
2015
Q1 | $4.02M | Buy |
89,322
+720
| +0.8% | +$32.4K | 0.21% | 141 |
|
|
2014
Q4 | $4.27M | Sell |
88,602
-314
| -0.4% | -$14.9K | 0.24% | 133 |
|
|
2014
Q3 | $4.26M | Buy |
88,916
+3,034
| +4% | +$147K | 0.24% | 134 |
|
|
2014
Q2 | $4.25M | Sell |
85,882
-1,680
| -2% | -$78.6K | 0.23% | 132 |
|
|
2014
Q1 | $4.12M | Sell |
87,562
-567
| -0.6% | -$26.1K | 0.23% | 133 |
|
|
2013
Q4 | $4.24M | Sell |
88,129
-13,557
| -13% | -$608K | 0.24% | 131 |
|
|
2013
Q3 | $4.25M | Sell |
101,686
-40,274
| -28% | -$1.74M | 0.25% | 133 |
|
|
2013
Q2 | $5.79M | Buy |
+141,960
| New | +$5.22M | 0.36% | 114 |
|
Other funds holding MET
Boston Common Asset Management's MET Position: Q2 2026 in Review
Boston Common Asset Management reduced its MetLife (MET) stake by 1.1% in Q2 2026, selling an estimated $99.3K and leaving 108,285 shares worth $9.16M. The position accounts for 0.54% of the portfolio, ranked #58.
Boston Common Asset Management first reported a position in MET in Q2 2013 and has held it in 35 quarters since. The position peaked at $26.8M in Q4 2022. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Boston Common Asset Management held 108,285 shares of MetLife worth $9.16M as of Q2 2026.
- Boston Common Asset Management sold 1,231 MetLife shares in Q2 2026, an estimated $99.3K.
- MetLife made up 0.54% of Boston Common Asset Management's portfolio in Q2 2026, its #58 holding.
- Boston Common Asset Management first reported a position in MetLife in Q2 2013 and has held it in 35 quarters since.
- Boston Common Asset Management's MetLife position peaked at $26.8M in Q4 2022.
- 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.